Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
By Bill Freeman A scientist who helped to discover the HIV virus said he has made progress toward producing an AIDS vaccine and hopes to launch a clinical trial in about a year. Dr. Robert Gallo, the director of the University of Maryland’s Institute for Human Virology, said results from animal studies were encouraging. JERUSALEM …
By Bill Freeman Progressive disease after HIV infection is inversely correlated with the presence of plasmacytoid dendritic cells (pDCs), a subset of the dendritic cell family and the major producers of type 1 interferon in the body. A JCI paper reports the mechanisms by which HIV-1 activates human pDCs. Progressive disease after HIV infection is …
By Bill Freeman Jon Rappoport just posted an article that asks an interesting question: In all germ-related illnesses, when you have developed antibodies it means your body has been successful in fighting the disease. You are not going to get sick. Why then is it, that when we talk about HIV and Aids, the presence …
By Bill Freeman Mark Sircus of IMVA, the International Medical Veritas Association warns that there is a thread of “technology of death” that dates back to pre-World War II times and that seems to be alive to this day. This notion, as strange as it might seem, is not far fetched for those who are …
By Bill Freeman The increased frequency of drug resistance in isolates of the AIDS virus, HIV, makes identification of new antiviral targets an urgent necessity. Host genes required to support the replication of HIV are a potential source of such novel targets, but relatively few appropriate target genes have been identified in animal cells thus …
By Bill Freeman The results of the world’s first phase 3 HIV vaccine efficacy trial are reported in the March 1 issue of The Journal of Infectious Diseases, now available online. Although the vaccine was ineffective in preventing HIV infection, the trial represents a landmark in the fight against HIV and offers the scientific community a …
By Bill Freeman A UCLA AIDS Institute study has discovered that two chemical compounds may help the immune systems of HIV-infected persons fight the disease without invasive gene therapy. Presented March 5 at the 2005 Palm Springs Symposium on HIV/AIDS, the new research demonstrates that the new compounds activate telomerase A UCLA AIDS Institute study …
By Bill Freeman Contrary to the prevailing belief that the HIV epidemic in the UK can be traced back to one source, a new study suggests that HIV spread via at least six independent virus introductions and subsequent transmission chains. The findings, published in the latest issue of the Proceedings of the National Academy of …
By Bill Freeman Mount Sinai School of Medicine researchers demonstrated that a gel applied in the vagina provides protection from both the human immunodeficiency virus (HIV) and the herpes simplex Virus. The study, presented at the 12th Conference on Retroviruses and Opportunistic Infections, is the first to show that a gel can retain anti-viral activity …
By Bill Freeman Structural biologists at Children’s Hospital Boston and Harvard Medical School have shown how a key part of the human immunodeficiency virus (HIV) changes shape, triggering other changes that allow the AIDS virus to enter and infect cells. Their findings, published in the Feb. 24 issue of the journal Nature, offer clues that …